Critical Care & Emergencies (all articles)
[Abstract Only] Randomized Trial: Intravenous Cetirizine Versus Intravenous Diphenhydramine for the Treatment of Acute Urticaria
12 Jul, 2020 | 23:57h | UTCIntravenous Cetirizine Versus Intravenous Diphenhydramine for the Treatment of Acute Urticaria: A Phase III Randomized Controlled Noninferiority Trial – Annals of Emergency Medicine (link to abstract – $ for full-text)
Cardiac Troponin for the Diagnosis and Risk-Stratification of Myocardial Injury in COVID-19
10 Jul, 2020 | 09:34h | UTC
Related Commentary on Twitter
Troponin increases, due to chronic myocardial injury, acute nonischemic myocardial injury or type 1 or 2 MI, are common in #COVID19 and associated with adverse outcomes. Learn more in this #JACC Review Topic of the Week: https://t.co/oOBjCCx8KJ @yadersandoval @JJheart_doc pic.twitter.com/r9HPCJ4Knd
— JACC Journals (@JACCJournals) July 8, 2020
Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic
10 Jul, 2020 | 09:30h | UTCIncidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic – JAMA Network Open
Commentary: Researchers find rise in broken heart syndrome during COVID-19 pandemic – Cleveland Clinic
Podcast: Acute Lung Injury in Covid-19
9 Jul, 2020 | 09:28h | UTCAudio Interview: Acute Lung Injury in Covid-19 – New England Journal of Medicine
COVID-19-associated Acute Respiratory Distress Syndrome: Is A Different Approach to Management Warranted?
8 Jul, 2020 | 01:02h | UTC
Meta-Analysis: Standardized Management for Hypoxemic Respiratory Failure and ARDS
8 Jul, 2020 | 01:01h | UTC
Opinion – One U.K. Trial is Transforming COVID-19 Treatment. Why Haven’t Others Delivered More Results?
6 Jul, 2020 | 08:58h | UTCStudy 1 – lopinavir-ritonavir: No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY
Study 2 – dexamethasone: Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 – Recovery Trial AND Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report – medRxiv
Study 3 – hydroxychloroquine: No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
WHO Discontinues Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19
6 Jul, 2020 | 09:02h | UTCCommentary: WHO says trials show malaria and HIV drugs don’t cut Covid-19 hospital deaths – The Guardian
Related Commentary on Twitter
WHO accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trial’s hydroxychloroquine and the lopinavir/ritonavir arms.
More https://t.co/dCxHqBIwtr#COVID19 #coronavirus
— World Health Organization (WHO) (@WHO) July 4, 2020
[Preprint] Randomized Trial: Convalescent Plasma for COVID-19
6 Jul, 2020 | 08:47h | UTCConvalescent Plasma for COVID-19. A randomized clinical trial – medRxiv
Related Commentary on Twitter
https://twitter.com/hildabast/status/1279625347214921729
Meta-Analysis: Acute Complications and Mortality in Hospitalized Patients with Covid-19
6 Jul, 2020 | 08:36h | UTC
Review: Neurological Associations of COVID-19
3 Jul, 2020 | 08:38h | UTCNeurological associations of COVID-19 – The Lancet Neurology
Contemporary Management of Acute Ischemic Stroke Across the Continuum: From TeleStroke to Intra-Arterial Management
3 Jul, 2020 | 08:28h | UTC
Review: COVID-19 and the Cardiovascular System
2 Jul, 2020 | 08:52h | UTC
Update of the Treatment of Nosocomial Pneumonia in the ICU
2 Jul, 2020 | 08:37h | UTCUpdate of the treatment of nosocomial pneumonia in the ICU – Critical Care
Editorial: Is a “Cytokine Storm” Relevant to COVID-19?
1 Jul, 2020 | 07:59h | UTCIs a “Cytokine Storm” Relevant to COVID-19? – JAMA Internal Medicine
Related Commentary on Twitter
NEW @JAMAInternalMed
Is a “Cytokine Storm” Relevant to #COVID19 ?
"Although the term cytokine storm conjures up dramatic imagery and has captured the attention of the mainstream and scientific media, the current data do not support its use"https://t.co/0NuCUHdBdq— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) June 30, 2020
Meta-Analysis: Outcomes from Intensive Care in Patients with COVID‐19
1 Jul, 2020 | 07:46h | UTC
Why COVID-19 Silent Hypoxemia is Baffling to Physicians
1 Jul, 2020 | 07:48h | UTCCommentary: Silent Hypoxemia from COVID-19 Explained – Journal Feed
Guideline Summary: Major Consensus Statement on IV Contrast Nephropathy
1 Jul, 2020 | 07:33h | UTCMajor Consensus Statement on IV Contrast Nephropathy – Journal Feed
Original Guideline: ACR/NKF Consensus Statement: “The Risk of Acute Kidney Injury Developing in Patients with Reduced Kidney Function Following Exposure to Intravenous Iodinated Contrast Media has Been Overstated” (Guideline and commentaries)
[Abstract Only] Meta-Analysis: The Prognostic Value of Syncope on Mortality in Patients with Pulmonary Embolism
1 Jul, 2020 | 07:31h | UTCCommentary: Does Syncope in PE Mean Increased Mortality? – Journal Feed
Press Release: No Clinical Benefit from Use of Lopinavir-ritonavir in Hospitalized COVID-19 Patients
30 Jun, 2020 | 08:08h | UTC
Opinion: Why N95 Should Be the Standard for All COVID-19 Inpatient Care
30 Jun, 2020 | 07:54h | UTCWhy N95 Should Be the Standard for All COVID-19 Inpatient Care – Annals of Internal Medicine
Recommendations for Hospital-Based Physical Therapists Managing Patients With COVID-19
29 Jun, 2020 | 09:16h | UTC
Updated Guidelines to Reduce Venous Thromboembolism in Trauma Patients
29 Jun, 2020 | 09:03h | UTC
Consensus Care Bundle for the Early Clinical Management of Acute Upper Gastrointestinal Bleeding
29 Jun, 2020 | 09:05h | UTC
Study: Home Pulse Oximetry Monitoring in COVID‐19 Patients Discharged from the Emergency Department Identifies Need for Hospitalization
29 Jun, 2020 | 09:10h | UTCCommentary: Pulse Oximetry in Outpatients with COVID-19 – NEJM Journal Watch